Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Br J Haematol. 2009 Mar 29;145(5):637–641. doi: 10.1111/j.1365-2141.2009.07670.x

Figure 1d.

Figure 1d

Event-free survival of patients according to gene expression profiling (GEP)-defined risk and the presence or absence of CA in both random sites and focal lesion sites (RS+/FL+). High-risk designation only lowers event-free survival expectations in 22 among the 236 patients lacking RS+/FL+ (“Not RS+/FL+”).